Default: Journal of Hematology and Oncology

ISSN:

Journal Home

Journal Guideline

Journal of Hematology and Oncology Q1 Unclaimed

BioMed Central Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Hematology and Oncology is a journal indexed in SJR in Molecular Biology and Hematology with an H index of 122. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1815 €. The scope of the journal is focused on haematology, oncology. It has an SJR impact factor of 6,046 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 6,046.

Journal of Hematology and Oncology focuses its scope in these topics and keywords: biomarkers, progression, modulating, multiple, myeloid, natural, nktldownstream, nsclc, pathogenesis, pathways, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

1815 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Journal of Hematology and Oncology

6,046

SJR Impact factor

122

H Index

171

Total Docs (Last Year)

500

Total Docs (3 years)

18367

Total Refs

11243

Total Cites (3 years)

436

Citable Docs (3 years)

20.88

Cites/Doc (2 years)

107.41

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


biomarkers, progression, modulating, multiple, myeloid, natural, nktldownstream, nsclc, pathogenesis, pathways, pathwayssmi, differentiation, proliferative, signaling, spectrum, src, srcrelated, statusimmunotherapy, suppresses, t, implicationsac, active, agents, bcell, bcl, biology, cell, flt, genitourinary, molecular, inhibitor, iodide, irrespective, killer, leukemia, leukemiapathogenesis, lymphoid, lymphoma, haematology, oncology

FAQS